AU Patent

AU2019257421B2 — Formulation for soft anticholinergic analogs

Assigned to Bodor Laboratories Inc · Expires 2021-10-21 · 5y expired

What this patent protects

Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anh…

USPTO Abstract

Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis. 11827911_1 (GHMatters) P104206.AU.1

Drugs covered by this patent

Patent Metadata

Patent number
AU2019257421B2
Jurisdiction
AU
Classification
—
Expires
2021-10-21
Drug substance claim
No
Drug product claim
No
Assignee
Bodor Laboratories Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.